We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The software is now included in Swoop’s standard software package, taking just minutes after scanning to assess and annotate the brain images. Read More
The drug was first approved in 2014 for treating type 2 diabetes and for reducing the risk of cardiovascular death in patients with type 2 diabetes. Read More
Cardiac CT combined with SQuEEZ analysis software “can provide clinicians with a normalized measurement to determine … [if] contractile function [is] normal or not normal,” the company said. Read More
The late-stage trial found that the safety and tolerability of the drug was consistent with its well-established safety profile, AstraZeneca said. Read More